Seeking Alpha


Send Message
View as an RSS Feed
View BGSmith's Comments BY TICKER:
Latest  |  Highest rated
  • Update: Cellceutix's Antibiotic Brilacidin Should Move Share Price Before Kevetrin Or Prurisol [View article]
    Nice update.
    CTIX making impressive strides with Brilacidin in short time since acquiring it.
    Kevetrin trial going great.
    Sep 14 05:22 AM | 5 Likes Like |Link to Comment
  • Kevetrin :The LeBron James Of Oncology [View instapost]
    Another signature Ellaruth write up. I am with you all the way.

    Quit giving the 3 stooges ink. Kevetrin has dwarfed them.
    Jul 25 10:51 PM | Likes Like |Link to Comment
  • Interview With Leo Ehrlich, Cellceutix CEO Following Acquisition Of PolyMedix Assets [View article]
    Very nicely done.
    This guy has done an amazing job in the last 2 years.
    Sep 18 09:41 AM | 1 Like Like |Link to Comment
  • Cellceutix Corporation: The Next Generation Of Cancer Treatment Has Arrived [View article]
    The most thorough analysis yet. Well done.
    Current shareholder looking forward to trial results.
    May 9 11:20 PM | 2 Likes Like |Link to Comment
  • The Amazing P53 Race [View article]
    Excellent presentation of pros and cons.
    I would add that CTIX management is absolutely top notch and they happen to own a ton of stock.
    Jan 19 11:17 AM | 1 Like Like |Link to Comment
  • Q&A: Cellceutix CEO Leo Ehrlich - Future Billion-Dollar Anti-Psoriasis Compound [View article]
    Thanks Progressive. Excellent interview.
    Jan 15 05:27 PM | 1 Like Like |Link to Comment
  • Why The Aspire Deal Is A Winner For Cellceutix Shareholders [View article]
    Terrific write-up.
    I see the Aspire financing as a watershed positive event for CTIX.
    My speculation is that Aspire attended the CTIX presentation in September and this financing is only one of the results from that meeting. Most likely Aspire has taken an equity position of at least 2 - 3 million shares in addition to what they may purchase under this financing. Putting this deal together in only 90 days is impressive and suggests it was top priority for both parties.

    Aspire obviously sees long term potential with CTIX and expects, with good reason, blockbuster price increases to accompany positive test results from either Kevetrin or Prurisol in 2013.
    So do I...
    Dec 24 01:17 AM | 1 Like Like |Link to Comment
  • Why The Aspire Deal Is A Winner For Cellceutix Shareholders [View article]
    Great info. Thanks.
    Dec 18 04:22 PM | Likes Like |Link to Comment
  • My 2013 Stock Of The Year: Cellceutix [View article]
    The insiders seem to agree that it is the stock to own in 2013 - they own 72%!
    Also my favorite.
    Dec 18 04:22 PM | 1 Like Like |Link to Comment
  • 3 Biotechs Racing Higher On Positive Developments [View article]
    What KarinCA said.
    No sense getting ahead of ourselves here.
    BUT, the fact that the 1st cohort did not exhibit any toxicity is itself major news.
    Dec 11 04:47 PM | Likes Like |Link to Comment